Literature DB >> 1801307

Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing.

E W Petersdorf1, A G Smith, A M Haase, P J Martin, J A Hansen.   

Abstract

We have used group-specific DNA amplification and sequence-specific oligonucleotide probe (SSOP) hybridization to study DRB1 sequence polymorphisms associated with DR3, DRw11(5), DRw12(5), DRw13(w6), DRw14(w6) and DRw8 alleles. Group-specific amplification of DRw52-associated DRB1 alleles was achieved using a 5' amplification primer designed to hybridize with a first hypervariable region (HVR) sequence common to all known alleles in this group, together with a 3' intron primer. Prospective SSOP typing of DR3, DRw11, DRw12, DRw13, DRw14 and DRw8 alleles was performed in 318 individuals, including 124 patients, 46 family members and 148 unrelated marrow donors. Among the 395 DRw52-associated DRB1 alleles tested in our study, a subtype corresponding to the previously defined alleles DRB1*0301-2 (DR3), DRB1*1101-4 (DR5), DRB1*1201-2 (DR5), DRB1*1301-5 (DRw6), DRB1*1401-2 and 1404 (DRw6), and DRB1*0801-4 (DRw8) could be assigned in all but 6 individuals (1.9%) tested. In addition to the 22 known alleles, we identified two new DRw6-associated alleles, DRB1*13.MW(1) and DRB1*14.GB(1). DRB1*13.MW typed serologically as DRw13 and was identical to DRB1*1301 except at codon 71 where AGG encodes arginine instead of GAG encoding glutamic acid. DRB1*14.GB represents a DRB1*1402 variant whose sequence at codon 86 encodes valine (GTG) instead of glycine (GGT). These results demonstrate that SSOP methods represent an efficient and precise approach for typing DRB1 alleles and for identifying potential novel variants previously unrecognized by conventional typing methods.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801307     DOI: 10.1111/j.1399-0039.1991.tb01891.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

1.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.

Authors:  Mark B Geyer; Judith S Jacobson; Jason Freedman; Diane George; Virginia Moore; Carmella van de Ven; Prakash Satwani; Monica Bhatia; James H Garvin; Mary Brigid Bradley; Lauren Harrison; Erin Morris; Phyllis Della-Latta; Joseph Schwartz; Lee A Baxter-Lowe; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2011-08-16       Impact factor: 6.998

Review 3.  "Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries".

Authors:  Mahmoud Aljurf; Daniel Weisdorf; Feras Alfraih; Jeff Szer; Carlheinz Müller; Dennis Confer; Shahrukh Hashmi; Nicolaus Kröger; Bronwen E Shaw; Hildegard Greinix; Mohamed A Kharfan-Dabaja; Lydia Foeken; Adriana Seber; Syed Ahmed; Areej El-Jawahri; Moheeb Al-Awwami; Yoshiko Atsuta; Marcelo Pasquini; Amr Hanbali; Hazzaa Alzahrani; Shinichiro Okamoto; Eliane Gluckman; Mohamad Mohty; Yoshihisa Kodera; Mary Horowitz; Dietger Niederwieser; Riad El Fakih
Journal:  Bone Marrow Transplant       Date:  2019-02-18       Impact factor: 5.483

4.  Distributions of HLA-A and -B alleles and haplotypes in the Yi ethnic minority of Yunnan, China: relationship to other populations.

Authors:  Bo-feng Zhu; Guang Yang; Chun-mei Shen; Hai-xia Qin; Shun-zhi Liu; Ya-jun Deng; Shuan-liang Fan; Li-bin Deng; Feng Chen; Ping Zhang; Jie Fang; Li-ping Chen; Hong-dan Wang; Zhen-yuan Wang; Rudolf Lucas
Journal:  J Zhejiang Univ Sci B       Date:  2010-02       Impact factor: 3.066

5.  An analysis of HLA-A, -B, and -DRB1 allele and haplotype frequencies of 21,918 residents living in Liaoning, China.

Authors:  Xiao-Feng Li; Xu Zhang; Yang Chen; Kun-Lian Zhang; Xiang-Jun Liu; Jian-Ping Li
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.